Your browser doesn't support javascript.
loading
[Chinese multicenter randomized trial of customized chemotherapy based on BRCA1 (breast cancer susceptibility gene 1)-RAP80 (receptor-associated protein 80) mRNA expression in advanced non-small cell lung cancer (NSCLC) patients].
Wei, J; Qian, X P; Zou, Z Y; Wang, L F; Yu, L X; You, C W; Song, Y; Lu, H Y; Hu, W J; Yan, J; Xu, X X; Chen, X F; Li, X Y; Wu, Q F; Zhou, Y; Zhang, F L; Liu, B R.
Afiliación
  • Wei J; The Comprehensive Cancer Center, Affiliated Drum Tower Hospital to Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing 210008, China.
  • Qian XP; The Comprehensive Cancer Center, Affiliated Drum Tower Hospital to Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing 210008, China.
  • Zou ZY; The Comprehensive Cancer Center, Affiliated Drum Tower Hospital to Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing 210008, China.
  • Wang LF; The Comprehensive Cancer Center, Affiliated Drum Tower Hospital to Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing 210008, China.
  • Yu LX; The Comprehensive Cancer Center, Affiliated Drum Tower Hospital to Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing 210008, China.
  • You CW; Department of Oncology, Suqian General Hospital, Suqian 223800, China.
  • Song Y; Department of Respiratory Medicine, Jinlin Hospital, Nanjing 210002, China.
  • Lu HY; Department of Oncology, Taizhou General Hospital, Taizhou 225300, China.
  • Hu WJ; The Comprehensive Cancer Center, Affiliated Drum Tower Hospital to Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing 210008, China.
  • Yan J; The Comprehensive Cancer Center, Affiliated Drum Tower Hospital to Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing 210008, China.
  • Xu XX; Department of Respiratory Medicine, Northern Jiangsu People's Hospital, Yangzhou 225001, China.
  • Chen XF; Department of Oncology, Huaian General Hospital, Huaian 223300, China.
  • Li XY; Department of Oncology, Affiliated Hospital to Zhengzhou University, Zhengzhou 450052 , China.
  • Wu QF; Department of Oncology, Yixing General Hospital, Yixing 214200, China.
  • Zhou Y; Department of Oncology, Yixing General Hospital, Yixing 214200, China.
  • Zhang FL; Department of Oncology, Maanshan General Hospital, Maanshan 243000, China.
  • Liu BR; The Comprehensive Cancer Center, Affiliated Drum Tower Hospital to Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing 210008, China.
Zhonghua Zhong Liu Za Zhi ; 38(11): 868-873, 2016 Nov 23.
Article en Zh | MEDLINE | ID: mdl-27998448
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Nucleares / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Portadoras / Carcinoma de Pulmón de Células no Pequeñas / Proteína BRCA1 / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: Zh Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Nucleares / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Portadoras / Carcinoma de Pulmón de Células no Pequeñas / Proteína BRCA1 / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: Zh Año: 2016 Tipo del documento: Article